These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31136639)

  • 21. Multi-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factors.
    Nuss JE; Kehn-Hall K; Benedict A; Costantino J; Ward M; Peyser BD; Retterer CJ; Tressler LE; Wanner LM; McGovern HF; Zaidi A; Anthony SM; Kota KP; Bavari S; Hakami RM
    PLoS One; 2014; 9(5):e93483. PubMed ID: 24809507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of Rift Valley fever virus in livestock during inter-epidemic period in Egypt, 2014/15.
    Mroz C; Gwida M; El-Ashker M; El-Diasty M; El-Beskawy M; Ziegler U; Eiden M; Groschup MH
    BMC Vet Res; 2017 Apr; 13(1):87. PubMed ID: 28381251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological evidence of inter-epizootic/inter-epidemic circulation of Rift Valley fever virus in domestic cattle in Kyela and Morogoro, Tanzania.
    Matiko MK; Salekwa LP; Kasanga CJ; Kimera SI; Evander M; Nyangi WP
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006931. PubMed ID: 30418975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection.
    de la Fuente C; Pinkham C; Dabbagh D; Beitzel B; Garrison A; Palacios G; Hodge KA; Petricoin EF; Schmaljohn C; Campbell CE; Narayanan A; Kehn-Hall K
    PLoS One; 2018; 13(2):e0191983. PubMed ID: 29408900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
    J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rift valley Fever in Kruger national park: do buffalo play a role in the inter-epidemic circulation of virus?
    Beechler BR; Bengis R; Swanepoel R; Paweska JT; Kemp A; van Vuren PJ; Joubert J; Ezenwa VO; Jolles AE
    Transbound Emerg Dis; 2015 Feb; 62(1):24-32. PubMed ID: 24330522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RIOK3 and Its Alternatively Spliced Isoform Have Disparate Roles in the Innate Immune Response to Rift Valley Fever Virus (MP12) Infection.
    Bisom TC; White LA; Lanchy JM; Lodmell JS
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors.
    Filone CM; Heise M; Doms RW; Bertolotti-Ciarlet A
    Virology; 2006 Dec 5-20; 356(1-2):155-64. PubMed ID: 16945399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis.
    Moser TS; Schieffer D; Cherry S
    PLoS Pathog; 2012; 8(4):e1002661. PubMed ID: 22532801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    Ly HJ; Lokugamage N; Nishiyama S; Ikegami T
    PLoS One; 2017; 12(9):e0185194. PubMed ID: 28926632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis.
    Harmon JR; Spengler JR; Coleman-McCray JD; Nichol ST; Spiropoulou CF; McElroy AK
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30258000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis.
    Harmon B; Schudel BR; Maar D; Kozina C; Ikegami T; Tseng CT; Negrete OA
    J Virol; 2012 Dec; 86(23):12954-70. PubMed ID: 22993156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production.
    Austin D; Baer A; Lundberg L; Shafagati N; Schoonmaker A; Narayanan A; Popova T; Panthier JJ; Kashanchi F; Bailey C; Kehn-Hall K
    PLoS One; 2012; 7(5):e36327. PubMed ID: 22574148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host-based processes as therapeutic targets for Rift Valley fever virus.
    Pinkham C; Ahmed A; Bracci N; Narayanan A; Kehn-Hall K
    Antiviral Res; 2018 Dec; 160():64-78. PubMed ID: 30316916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration in the Culex pipiens transcriptome reveals diverse mechanisms of the mosquito immune system implicated upon Rift Valley fever phlebovirus exposure.
    Núñez AI; Esteve-Codina A; Gómez-Garrido J; Brustolin M; Talavera S; Berdugo M; Dabad M; Alioto T; Bensaid A; Busquets N
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008870. PubMed ID: 33301456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H; Lorenzo G; Rodriguez F; Brun A
    Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rift Valley fever virus infection in golden Syrian hamsters.
    Scharton D; Van Wettere AJ; Bailey KW; Vest Z; Westover JB; Siddharthan V; Gowen BB
    PLoS One; 2015; 10(1):e0116722. PubMed ID: 25607955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and evaluation of antivirals for Rift Valley fever virus.
    Lang Y; Li Y; Jasperson D; Henningson J; Lee J; Ma J; Li Y; Duff M; Liu H; Bai D; McVey S; Richt JA; Ikegami T; Wilson WC; Ma W
    Vet Microbiol; 2019 Mar; 230():110-116. PubMed ID: 30827375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.